PlainPharmaWatch

CMS Open Payments · Tool

MIM Software Inc. vs Pathway Medical Partners, LLC

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

MIM Software Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 1,538, versus 1,140 for the other company. Its single largest recorded recipient represents 21.8% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

MIM Software Inc.
HHI 1,538 · top recipient 21.8%
Ranked #851 of 1,838 companies by HHI
Pathway Medical Partners, LLC
HHI 1,140 · top recipient 20.0%
Ranked #971 of 1,838 companies by HHI

Payment Overview

Company A

MIM Software Inc.

Total Payments
$67.1K
% of Industry
0.0%
Transactions
50
Avg per Transaction
$1.3K
Recipients
50
Avg per Recipient
$1.3K
Payment Types
4
Top Payment Type
Long-Term Medical Supply or Device Loan
Total Payments
$66.0K
% of Industry
0.0%
Transactions
33
Avg per Transaction
$2.0K
Recipients
33
Avg per Recipient
$2.0K
Payment Types
1
Top Payment Type
Education

Highlighted values indicate the higher figure for each metric.

Total payments compared

MIM Software Inc. vs Pathway Medical Partners, LLC - total reported payments in CMS Open Payments PY2024

MIM Software Inc.$67.1KPathway Medical Partners, L…$66.0K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

MIM Software Inc.

Long-Term Medical Supply or Device Loan $34.1K

50.8%

Consulting Fee $26.3K

39.2%

Compensation for Services Other Than Consulting $5.6K

8.3%

Food and Beverage $1.1K

1.6%

Pathway Medical Partners, LLC

Education $66.0K

100.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

MIM Software Inc.

  1. 1

    The Johns Hopkins Hospital

    $14,631.00 · 1 txns

  2. 2

    Ut Md Anderson Cancer Center

    $12,820.00 · 1 txns

  3. 3

    JEAN-PIERRE OBEID

    $12,323.50 · 1 txns

  4. 4

    HUBERT JEAN VESSELLE

    $9,600.00 · 12 txns

  5. 5

    Uci Medical Center

    $6,667.00 · 1 txns

Pathway Medical Partners, LLC

  1. 1

    BRIAN BURGESS

    $13,200.00 · 6 txns

  2. 2

    MOIZ HASSAN

    $8,000.00 · 4 txns

  3. 3

    STEVEN JASONOWICZ

    $8,000.00 · 4 txns

  4. 4

    JONATHAN HOOK

    $8,000.00 · 4 txns

  5. 5

    ALEXANDER MCKANNA

    $6,800.00 · 4 txns

Summary Comparison

Metric MIM Software Inc. Pathway Medical Partners, LLC
Total Payments $67.1K $66.0K
% of Industry Total 0.0% 0.0%
Transaction Count 50 33
Avg per Transaction $1.3K $2.0K
Recipient Count 50 33
Avg per Recipient $1.3K $2.0K
Payment Type Count 4 1
Top Payment Type Long-Term Medical Supply or Device Loan Education

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.